Luminous Medical

Luminous Medical was a medical technology company that specialized in the development of automated glucose monitoring systems for hospital intensive care units. The company's core technology utilized mid-infrared spectroscopy to provide continuous, real-time blood glucose measurements, aiming to replace intermittent manual testing. By providing high-frequency data, the system was designed to help clinicians maintain tight glycemic control in critically ill patients, thereby reducing mortality and morbidity associated with blood sugar fluctuations. Founded in 2005 and headquartered in Carlsbad, California, Luminous Medical attracted significant venture capital from firms like MPM Capital and De Novo Ventures. In 2009, the company was acquired by Inverness Medical Innovations (now part of Abbott) to integrate its monitoring technology into a broader diagnostic platform.